1. Morris, R. T. The ovarian graft. New York Med. J. 62, 436 (1895).

2. Favre-Inhofer, A., Rafii, A., Carbonnel, M., Revaux, A. & Ayoubi, J. M. Uterine transplantation: review in human research. J. Gynecol. Obstet. Hum. Reprod. 47, 213–221 (2018).

3. Rodriguez, K. M. & Pastuszak, A. W. A history of penile implants. Transl. Androl. Urol. 6, S851–S857 (2017).

4. Girsdansky, J. & Newman, H. F. Use of a vitallium testicular implant. Am. J. Surg. 53, 514 (1941).

5. Steptoe, P. C. & Edwards, R. G. Birth after the reimplantation of a human embryo. Lancet 312, 366 (1978).

6. Silber, S. J. Transplantation of a human testis for anorchia. Fertil. Steril. 30, 181–187 (1978).

7. Zeilmaker, G. H., Alberda, A. T., van Gent, I., Rijkmans, C. M. P. M. & Drogendijk, A. C. Two pregnancies following transfer of intact frozen-thawed embryos. Fertil. Steril. 42, 293–296 (1984).

8. Chen, C. Pregnancy after human oocyte cryopreservation. Lancet 1, 884–886 (1986).

9. Palermo, G., Joris, H., Devroey, P. & Van Steirteghem, A. C. Pregnancies after intracytoplasmic injection of single spermatozoon into an oocyte. Lancet 340, 17–18 (1992).

10. Donnez, J. et al. Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet 364, 1405–1410 (2004).

11. Hilders, C. G., Baranski, A. G., Peters, L., Ramkhelawan, A. & Trimbos, J. B. Successful human ovarian autotransplantation to the upper arm. Cancer 101, 2771–2778 (2004).

12. Jadoul, P. et al. Laparoscopic ovariectomy for whole human ovary cryopreservation: technical aspects. Fertil. Steril. 87, 971–975 (2007).

13. Woodruff, T. K. The emergence of a new interdiscipline: oncofertility. Cancer Treat. Res. 138, 3–11 (2007).

14. Xu, M., Kreeger, P. K., Shea, L. D. & Woodruff, T. K. Tissue-engineered follicles produce live, fertile offspring. Tissue Eng. 12, 2739–2746 (2006).

15. Raya-Rivera, A. M. et al. Tissue-engineered autologous vaginal organs in patients: a pilot cohort study. Lancet 384, 329–336 (2014).

16. Xiao, S. et al. In vitro follicle growth supports human oocyte meiotic maturation. Sci. Rep. 5, 17323 (2015).

17. Brännström, M. et al. Livebirth after uterus transplantation. Lancet 385, 607–616 (2015).

18. Xiao, S. et al. A microfluidic culture model of the human reproductive tract and 28-day menstrual cycle. Nat. Commun. 8, 14584 (2017).

19. Partridge, E. A. et al. An extra-uterine system to physiologically support the extreme premature lamb. Nat. Commun. 8, 15112 (2017).

20. Laronda, M. M. et al. A bioprosthetic ovary created using 3D printed microporous scaffolds restores ovarian function in sterilized mice. Nat. Commun. 8, 15261 (2017).

21. Botman, O. & Wyns, C. Induced pluripotent stem cell potential in medicine, specifically focused on reproductive medicine. Front. Surg. 1, 5 (2014).

22. Amini Mahabadi, J. et al. Derivation of male germ cells from induced pluripotent stem cells by inducers: a review. Cytotherapy 20, 279–290 (2018).

23. Poels, J. et al. Transplantation of testicular tissue in alginate hydrogel loaded with VEGF nanoparticles improves spermatogonial recovery. J. Control. Release 234, 79–89 (2016).

24. Shikanov, A. et al. Fibrin encapsulation and vascular endothelial growth factor delivery promotes ovarian graft survival in mice. Tissue Eng. Part A 17, 3095–3104 (2011).

25. Ensign, L. M., Cone, R. & Hanes, J. Nanoparticle-based drug delivery to the vagina: a review. J. Control. Release 190, 500–514 (2014).

26. Tanaka, A. et al. Effect of sustained release of basic fibroblast growth factor using biodegradable gelatin hydrogels on frozen-thawed human ovarian tissue in a xenograft model. J. Obstet. Gynaecol. Res. 44, 1947–1955 (2018).

27. Prakapenka, A. V., Bimonte-Nelson, H. A. & Sirianni, R. W. Engineering poly(lactic-co-glycolic acid) (PLGA) micro- and nano-carriers for controlled delivery of 17β-estradiol. Ann. Biomed. Eng. 45, 1697–1709 (2017).

28. Kashaninejad, N., Shiddiky, M. J. A. & Nguyen, N.-T. Advances in microfluidics-based assisted reproductive technology: from sperm sorter to reproductive system-on-a-chip. Adv. Biosyst. 2, 1700197 (2018).

29. Weng, L. et al. On-chip oocyte denudation from cumulus-oocyte complexes for assisted reproductive therapy. Lab Chip 18, 3892–3902 (2018).

30. Strauss, J. F. & Barbieri, R. L. Yen and Jaffe’s Reproductive Endocrinology (Elsevier, 2014).

31. Saunders, P. T. K. et al. Differential expression of oestrogen receptor alpha and beta proteins in the testes and male reproductive system of human and non-human primates. Mol. Hum. Reprod. 7, 227–236 (2001).

32. Toutain, P.-L., Ferran, A. & Bousquet-Mélou, A. in Comparative and Veterinary Pharmacology (eds Cunningham, F. et al.) 19–48 (Springer, 2010).

33. Sato, J., Nasu, M. & Tsuchitani, M. Comparative histopathology of the estrous or menstrual cycle in laboratory animals. J. Toxicol. Pathol. 29, 155–162 (2016).

34. Kanatsu-Shinohara, M. et al. Reconstitution of mouse spermatogonial stem cell niches in culture. Cell Stem Cell 11, 567–578 (2012).

35. Bylander, A. et al. Rapid effects of progesterone on ciliary beat frequency in the mouse fallopian tube. Reprod. Biol. Endocrinol. 8, 48 (2010).

36. Cunha, G. R. et al. The endocrinology and developmental biology of the prostate. Endocr. Rev. 8, 338–362 (1987).

37. Roberts, R. O. et al. Androgen receptor gene polymorphisms and increased risk of urologic measures of benign prostatic hyperplasia. Am. J. Epidemiol. 159, 269–276 (2004).

38. Goldenberg, S. L., Koupparis, A. & Robinson, M. E. Differing levels of testosterone and the prostate: a physiological interplay. Nat. Rev. Urol. 8, 365–377 (2011).

39. O’Shaughnessy, P. J. Hormonal control of germ cell development and spermatogenesis. Semin. Cell Dev. Biol. 29, 55–65 (2014).

40. Herbst, K. L. & Bhasin, S. Testosterone action on skeletal muscle. Curr. Opin. Clin. Nutr. Metab. Care 7, 271–277 (2004).

41. Karsenty, G. & Oury, F. Regulation of male fertility by the bone-derived hormone osteocalcin. Mol. Cell. Endocrinol. 382, 521–526 (2014).

42. Oury, F. et al. Osteocalcin regulates murine and human fertility through a pancreas-bone-testis axis. J. Clin. Invest. 123, 2421–2433 (2013).

43. Kim, A. M., Tingen, C. M. & Woodruff, T. K. Sex bias in trials and treatment must end. Nature 465, 688–689 (2010).

44. Nicodemus, G. D. & Bryant, S. J. Cell encapsulation in biodegradable hydrogels for tissue engineering applications. Tissue Eng. Part B Rev. 14, 149–165 (2008).

45. Khetan, S. & Burdick, J. Cellular encapsulation in 3D hydrogels for tissue engineering. J. Vis. Exp. 32, 1590 (2009).

46. West, E. R., Shea, L. D. & Woodruff, T. K. Engineering the follicle microenvironment. Semin. Reprod. Med. 25, 287–299 (2007).

47. Joo, S. et al. The effect of collagen hydrogel on 3D culture of ovarian follicles. Biomed. Mater. 11, 065009 (2016).

48. Skory, R. M., Xu, Y., Shea, L. D. & Woodruff, T. K. Engineering the ovarian cycle using in vitro follicle culture. Hum. Reprod. 30, 1386–1395 (2015).

49. Amorim, C. A., Van Langendonckt, A., David, A., Dolmans, M.-M. & Donnez, J. Survival of human pre-antral follicles after cryopreservation of ovarian tissue, follicular isolation and in vitro culture in a calcium alginate matrix. Hum. Reprod. 24, 92–99 (2008).

50. Pangas, S. A., Saudye, H., Shea, L. D. & Woodruff, T. K. Novel approach for the three-dimensional culture of granulosa cell–oocyte complexes. Tissue Eng. 9, 1013–1021 (2003).

51. Xu, J. et al. Fibrin promotes development and function of macaque primary follicles during encapsulated three-dimensional culture. Hum. Reprod. 28, 2187–2200 (2013).

52. Desai, N., Abdelhafez, F., Calabro, A. & Falcone, T. Three dimensional culture of fresh and vitrified mouse pre-antral follicles in a hyaluronan-based hydrogel: a preliminary investigation of a novel biomaterial for in vitro follicle maturation. Reprod. Biol. Endocrinol. 10, 29 (2012).

53. Shikanov, A., Smith, R. M., Xu, M., Woodruff, T. K. & Shea, L. D. Hydrogel network design using multifunctional macromers to coordinate tissue maturation in ovarian follicle culture. Biomaterials 32, 2524–2531 (2011).

54. Shikanov, A., Xu, M., Woodruff, T. K. & Shea, L. D. Interpenetrating fibrin–alginate matrices for in vitro ovarian follicle development. Biomaterials 30, 5476–5485 (2009).

55. Choi, J. K., Agarwal, P., Huang, H., Zhao, S. & He, X. The crucial role of mechanical heterogeneity in regulating follicle development and ovulation with engineered ovarian microtissue. Biomaterials 35, 5122–5128 (2014).

56. Lebbe, M. & Woodruff, T. K. Involvement of androgens in ovarian health and disease. Mol. Hum. Reprod. 19, 828–837 (2013).

57. West-Farrell, E. R. et al. The mouse follicle microenvironment regulates antrum formation and steroid production: alterations in gene expression profiles. Biol. Reprod. 80, 432–439 (2009).

58. Alves-Lopes, J. P., Söder, O. & Stukenborg, J. B. Testicular organoid generation by a novel in vitro three-layer gradient system. Biomaterials 130, 76–89 (2017).

59. Gholami, K., Pourmand, G., Koruji, M., Ashouri, S. & Abbasi, M. Organ culture of seminiferous tubules using a modified soft agar culture system. Stem Cell Res. Ther. 9, 249 (2018).

60. Vermeulen, M. et al. Generation of organized porcine testicular organoids in solubilized hydrogels from decellularized extracellular matrix. Int. J. Mol. Sci. 20, 5476 (2019).

61. Kessler, M. et al. The Notch and Wnt pathways regulate stemness and differentiation in human fallopian tube organoids. Nat. Commun. 6, 8989 (2015).

62. Zambuto, S. G., Clancy, K. B. H. & Harley, B. A. C. A gelatin hydrogel to study endometrial angiogenesis and trophoblast invasion. Interface Focus 9, 20190016 (2019).

63. Crapo, P. M., Gilbert, T. W. & Badylak, S. F. An overview of tissue and whole organ decellularization processes. Biomaterials 32, 3233–3243 (2011).

64. Laronda, M. M. et al. Initiation of puberty in mice following decellularized ovary transplant. Biomaterials 50, 20–29 (2015).

65. Eivazkhani, F. et al. Evaluating two ovarian decellularization methods in three species. Mater. Sci. Eng. C 102, 670–682 (2019).

66. Hassanpour, A., Talaei-Khozani, T., Kargar-Abarghouei, E., Razban, V. & Vojdani, Z. Decellularized human ovarian scaffold based on a sodium lauryl ester sulfate (SLES)-treated protocol, as a natural three-dimensional scaffold for construction of bioengineered ovaries. Stem Cell Res. Ther. 9, 252 (2018).

67. Alshaikh, A. B. et al. Decellularization of the mouse ovary: comparison of different scaffold generation protocols for future ovarian bioengineering. J. Ovarian Res. 12, 58 (2019).

68. Mirzaeian, L. et al. Optimizing the cell seeding protocol to human decellularized ovarian scaffold: Application of dynamic system for bio-engineering. Cell J. 22, 227–235 (2019).

69. Hiraoka, T. et al. STAT3 accelerates uterine epithelial regeneration in a mouse model of decellularized uterine matrix transplantation. JCI Insight 1, e87591 (2016).

70. Hellström, M. et al. Bioengineered uterine tissue supports pregnancy in a rat model. Fertil. Steril. 106, 487–496 (2016).

71. Campo, H. et al. De- and recellularization of the pig uterus: a bioengineering pilot study. Biol. Reprod. 96, 34–45 (2017).

72. Olalekan, S. A., Burdette, J. E., Getsios, S., Woodruff, T. K. & Kim, J. J. Development of a novel human recellularized endometrium that responds to a 28-day hormone treatment. Biol. Reprod. 96, 971–981 (2017).

73. Miyazaki, K. & Maruyama, T. Partial regeneration and reconstruction of the rat uterus through recellularization of a decellularized uterine matrix. Biomaterials 35, 8791–8800 (2014).

74. Daryabari, S. S. et al. Development of an efficient perfusion-based protocol for whole-organ decellularization of the ovine uterus as a human-sized model and in vivo application of the bioscaffolds. J. Assist. Reprod. Genet. 36, 1211–1223 (2019).

75. Baert, Y. & Goossens, E. in Methods in Molecular Biology (Ed. Turksen, K.) 121–127 (Humana Press, 2017).

76. Vermeulen, M., del Vento, F., de Michele, F., Poels, J. & Wyns, C. Development of a cytocompatible scaffold from pig immature testicular tissue allowing human Sertoli cell attachment, proliferation and functionality. Int. J. Mol. Sci. 19, 227 (2018).

77. Kargar-Abarghouei, E., Vojdani, Z., Hassanpour, A., Alaee, S. & Talaei-Khozani, T. Characterization, recellularization, and transplantation of rat decellularized testis scaffold with bone marrow-derived mesenchymal stem cells. Stem Cell Res. Ther. 9, 324 (2018).

78. Akbarzadeh, A. et al. Decellularised whole ovine testis as a potential bio-scaffold for tissue engineering. Reprod. Fertil. Dev. 31, 1665–1673 (2019).

79. Barreto, R. S. N., Romagnolli, P., Fratini, P., Mess, A. M. & Miglino, M. A. Mouse placental scaffolds: a three-dimensional environment model for recellularization. J. Tissue Eng. 10, 1–11 (2019).

80. Favaron, P. O. et al. Establishment of 3-dimensional scaffolds from hemochorial placentas. Placenta 81, 32–41 (2019).

81. Motamed, M. et al. Tissue engineered human amniotic membrane application in mouse ovarian follicular culture. Ann. Biomed. Eng. 45, 1664–1675 (2017).

82. Oktay, K., Bedoschi, G., Pacheco, F., Turan, V. & Emirdar, V. First pregnancies, live birth, and in vitro fertilization outcomes after transplantation of frozen-banked ovarian tissue with a human extracellular matrix scaffold using robot-assisted minimally invasive surgery. Am. J. Obstet. Gynecol. 214, 94.e1–94.e9 (2016).

83. Baert, Y. et al. Derivation and characterization of a cytocompatible scaffold from human testis. Hum. Reprod. 30, 256–267 (2015).

84. Baert, Y. et al. Primary human testicular cells self-organize into organoids with testicular properties. Stem Cell Rep. 8, 30–38 (2017).

85. Baert, Y., Rombaut, C. & Goossens, E. in Methods in Molecular Biology (Ed. Turksen, K.) 283–290 (Humana, 2017).

86. Park, M. H. et al. Effects of extracellular matrix protein-derived signaling on the maintenance of the undifferentiated state of spermatogonial stem cells from porcine neonatal testis. Asian-Australasian J. Anim. Sci. 29, 1398–1406 (2016).

87. Scarrit, M. E., Pashos, N. C. & Bunnell, B. A. A review of cellularization strategies for tissue engineering of whole organs. Front. Bioeng. Biotechnol. 3, 43 (2015).

88. Jakus, A. E. et al. “Tissue papers” from organ-specific decellularized extracellular matrices. Adv. Funct. Mater. 27, 1700992 (2017).

89. Rezaei Topraggaleh, T., Rezazadeh Valojerdi, M., Montazeri, L. & Baharvand, H. A testis-derived macroporous 3D scaffold as a platform for the generation of mouse testicular organoids. Biomater. Sci. 7, 1422–1436 (2019).

90. Henning, N. F., LeDuc, R. D., Even, K. A. & Laronda, M. M. Proteomic analyses of decellularized porcine ovaries identified new matrisome proteins and spatial differences across and within ovarian compartments. Sci. Rep. 9, 20001 (2019).

91. Ouni, E., Vertommen, D., Chiti, M. C., Dolmans, M. M. & Amorim, C. A. A draft map of the human ovarian proteome for tissue engineering and clinical applications. Mol. Cell. Proteomics 18, S159–S173 (2019).

92. Murphy, S. V. & Atala, A. 3D bioprinting of tissues and organs. Nat. Biotechnol. 32, 773–785 (2014).

93. Billiet, T., Vandenhaute, M., Schelfhout, J., Van Vlierberghe, S. & Dubruel, P. A review of trends and limitations in hydrogel-rapid prototyping for tissue engineering. Biomaterials 33, 6020–6041 (2012).

94. Raffel, N. et al. Novel approach for the assessment of ovarian follicles infiltration in polymeric electrospun patterned scaffolds. PLoS ONE 14, e0215985 (2019).

95. Baert, Y., Dvorakova-Hortova, K., Margaryan, H. & Goossens, E. Mouse in vitro spermatogenesis on alginate-based 3D bioprinted scaffolds. Biofabrication 11, 035011 (2019).

96. Kuo, C.-Y. et al. Development of a 3D printed, bioengineered placenta model to evaluate the role of trophoblast migration in preeclampsia. ACS Biomater. Sci. Eng. 2, 1817–1826 (2016).

97. Kuo, C. Y. et al. Trophoblast–endothelium signaling involves angiogenesis and apoptosis in a dynamic bioprinted placenta model. Biotechnol. Bioeng. 116, 181–192 (2019).

98. Paul, K. et al. 3D bioprinted endometrial stem cells on melt electrospun poly ε-caprolactone mesh for pelvic floor application promote anti-inflammatory responses in mice. Acta Biomater. 97, 162–176 (2019).

99. Ovsianikov, A., Khademhosseini, A. & Mironov, V. The synergy of scaffold-based and scaffold-free tissue engineering strategies. Trends Biotechnol. 36, 348–357 (2018).

100. Huch, M. & Koo, B.-K. Modeling mouse and human development using organoid cultures. Development 142, 3113–3125 (2015).

101. Cui, X., Hartanto, Y. & Zhang, H. Advances in multicellular spheroids formation. J. Roy. Soc. Interface 14, 20160877 (2017).

102. De Gregorio, V. et al. An engineered cell-instructive stroma for the fabrication of a novel full thickness human cervix equivalent in vitro. Adv. Healthc. Mater. 6, 1601199 (2017).

103. Karolina Zuk, A., Wen, X., Dilworth, S., Li, D. & Ghali, L. Modeling and validating three dimensional human normal cervix and cervical cancer tissues in vitro. J. Biomed. Res. 31, 240–247 (2017).

104. von Kopylow, K. et al. Dynamics, ultrastructure and gene expression of human in vitro organized testis cells from testicular sperm extraction biopsies. Mol. Hum. Reprod. 24, 123–134 (2018).

105. Higaki, S. et al. In vitro differentiation of fertile sperm from cryopreserved spermatogonia of the endangered endemic cyprinid honmoroko (Gnathopogon caerulescens). Sci. Rep. 7, 42852 (2017).

106. Azizi, H., Skutella, T. & Shahverdi, A. Generation of mouse spermatogonial stem-cell-colonies in a non-adherent culture. Cell J. 19, 238–249 (2017).

107. Lin, Z. Y. C. et al. Sphere-formation culture of testicular germ cells in the common marmoset, a small New World monkey. Primates 57, 129–135 (2016).

108. Pendergraft, S. S., Sadri-Ardekani, H., Atala, A. & Bishop, C. E. Three-dimensional testicular organoid: a novel tool for the study of human spermatogenesis and gonadotoxicity in vitro. Biol. Reprod. 96, 720–732 (2017).

109. Strange, D. P. et al. Human testicular organoid system as a novel tool to study Zika virus pathogenesis. Emerg. Microbes Infect. 7, 82 (2018).

110. Murphy, A. R., Wiwatpanit, T., Lu, Z., Davaadelger, B. & Kim, J. J. Generation of multicellular human primary endometrial organoids. J. Vis. Exp. 152, e60384 (2019).

111. Sakib, S., Yu, Y., Voigt, A., Ungrin, M. & Dobrinski, I. Generation of porcine testicular organoids with testis specific architecture using microwell culture. J. Vis. Exp. 152, e60387 (2019).

112. Sakib, S. et al. Formation of organotypic testicular organoids in microwell culture†. Biol. Reprod. 100, 1648–1660 (2019).

113. Zhang, B., Korolj, A., Lai, B. F. L. & Radisic, M. Advances in organ-on-a-chip engineering. Nat. Rev. Mater. 3, 257–278 (2018).

114. Bhatia, S. N. & Ingber, D. E. Microfluidic organs-on-chips. Nat. Biotechnol. 32, 760–772 (2014).

115. Kim, M. S., Bae, C. Y., Wee, G., Han, Y. M. & Park, J. K. A microfluidic in vitro cultivation system for mechanical stimulation of bovine embryos. Electrophoresis 30, 3276–3282 (2009).

116. Zhu, J. et al. Human fallopian tube epithelium co-culture with murine ovarian follicles reveals crosstalk in the reproductive cycle. Mol. Hum. Reprod. 22, 756–767 (2016).

117. García, E. V. et al. Bovine embryo-oviduct interaction in vitro reveals an early cross talk mediated by BMP signaling. Reproduction 153, 631–643 (2017).

118. Ferraz, M. A. M. M. et al. Improved bovine embryo production in an oviduct-on-a-chip system: prevention of poly-spermic fertilization and parthenogenic activation. Lab Chip 17, 905–916 (2017).

119. Komeya, M. et al. Long-term ex vivo maintenance of testis tissues producing fertile sperm in a microfluidic device. Sci. Rep. 6, 21472 (2016).

120. De Michele, F. et al. Preserved seminiferous tubule integrity with spermatogonial survival and induction of Sertoli and Leydig cell maturation after long-term organotypic culture of prepubertal human testicular tissue. Hum. Reprod. 32, 32–45 (2017).

121. Yamanaka, H. et al. A monolayer microfluidic device supporting mouse spermatogenesis with improved visibility. Biochem. Biophys. Res. Commun. 500, 885–891 (2018).

122. Gnecco, J. S. et al. Compartmentalized culture of perivascular stroma and endothelial cells in a microfluidic model of the human endometrium. Ann. Biomed. Eng. 45, 1758–1769 (2017).

123. Lee, J. S. et al. Placenta-on-a-chip: a novel platform to study the biology of the human placenta. J. Matern. Neonatal Med. 29, 1046–1054 (2016).

124. Blundell, C. et al. A microphysiological model of the human placental barrier. Lab Chip 16, 3065–3073 (2016).

125. Nishiguchi, A. et al. In vitro placenta barrier model using primary human trophoblasts, underlying connective tissue and vascular endothelium. Biomaterials 192, 140–148 (2019).

126. Pemathilaka, R. L., Caplin, J. D., Aykar, S. S., Montazami, R. & Hashemi, N. N. Placenta-on-a-chip: in vitro study of caffeine transport across placental barrier using liquid chromatography mass spectrometry. Glob. Challenges 3, 1800112 (2019).

127. Arumugasaamy, N., Hurley-Novatny, A., Lembong, J., Kim, P. C. W. & Fisher, J. P. Assessing SSRIs’ effects on fetal cardiomyocytes utilizing placenta-fetus model. Acta Biomater. 99, 258–268 (2019).

128. Arumugasaamy, N., Gudelsky, A., Hurley-Novatny, A., Kim, P. C. W. & Fisher, J. P. Model placental barrier phenotypic response to fluoxetine and sertraline: a comparative study. Adv. Healthc. Mater. 8, e1900476 (2019).

129. Yin, F. et al. A 3D human placenta-on-a-chip model to probe nanoparticle exposure at the placental barrier. Toxicol. Vitr. 54, 105–113 (2019).

130. Arumugasaamy, N. et al. Biomimetic placenta-fetus model demonstrating maternal–fetal transmission and fetal neural toxicity of Zika virus. Ann. Biomed. Eng. 46, 1963–1974 (2018).

131. Abbas, Y. et al. A microfluidics assay to study invasion of human placental trophoblast cells. J. R. Soc. Interface 14, 20170131 (2017).

132. Li, S.-S. et al. Modeling ovarian cancer multicellular spheroid behavior in a dynamic 3D peritoneal microdevice. J. Vis. Exp. 120, e55337 (2017).

133. Zhou, H. et al. Hydrogel based 3-dimensional (3D) system for toxicity and high-throughput (HTP) analysis for cultured murine ovarian follicles. PLoS ONE 10, e0140205 (2015).

134. Xiao, S. et al. Doxorubicin has dose-dependent toxicity on mouse ovarian follicle development, hormone secretion, and oocyte maturation. Toxicol. Sci. 157, 320–329 (2017).

135. Meng, C.-X., Andersson, K. L., Bentin-Ley, U., Gemzell-Danielsson, K. & Lalitkumar, P. G. L. Effect of levonorgestrel and mifepristone on endometrial receptivity markers in a three-dimensional human endometrial cell culture model. Fertil. Steril. 91, 256–264 (2009).

136. Laronda, M. M., Burdette, J. E., Kim, J. & Woodruff, T. K. Recreating the female reproductive tract in vitro using iPSC technology in a linked microfluidics environment. Stem Cell Res. Ther. 4, S13 (2013).

137. Cooper, A. R. et al. The time is now for a new approach to primary ovarian insufficiency. Fertil. Steril. 95, 1890–1897 (2011).

138. De Vos, M., Smitz, J. & Woodruff, T. K. Fertility preservation in women with cancer. Lancet 384, 1302–1310 (2014).

139. Jeruss, J. S. & Woodruff, T. K. Preservation of fertility in patients with cancer. N. Engl. J. Med. 360, 902–911 (2009).

140. Donnez, J. & Dolmans, M.-M. Fertility preservation in women. N. Engl. J. Med. 377, 1657–1665 (2017).

141. Donnez, J., Dolmans, M.-M., Diaz, C. & Pellicer, A. Ovarian cortex transplantation: time to move on from experimental studies to open clinical application. Fertil. Steril. 104, 1097–1098 (2015).

142. Amorim, C. A. & Shikanov, A. The artificial ovary: current status and future perspectives. Future Oncol. 12, 2323–2332 (2016).

143. Kniazeva, E. et al. Primordial follicle transplantation within designer biomaterial grafts produce live births in a mouse infertility model. Sci. Rep. 5, 17709 (2015).

144. Rios, P. D. et al. Retrievable hydrogels for ovarian follicle transplantation and oocyte collection. Biotechnol. Bioeng. 115, 2075–2086 (2018).

145. Vanacker, J. et al. Transplantation of an alginate-matrigel matrix containing isolated ovarian cells: first step in developing a biodegradable scaffold to transplant isolated preantral follicles and ovarian cells. Biomaterials 33, 6079–6085 (2012).

146. Day, J. R. et al. Immunoisolating poly(ethylene glycol) based capsules support ovarian tissue survival to restore endocrine function. J. Biomed. Mater. Res. Part A 106, 1381–1389 (2018).

147. Felder, S. et al. Reconstruction of the ovary microenvironment utilizing macroporous scaffold with affinity-bound growth factors. Biomaterials 205, 11–22 (2019).

148. Sittadjody, S. et al. Encapsulation of mesenchymal stem cells in 3D ovarian cell constructs promotes stable and long-term hormone secretion with improved physiological outcomes in a syngeneic rat model. Ann. Biomed. Eng. 48, 1058–1070 (2020).

149. David, A., Day, J. & Shikanov, A. Immunoisolation to prevent tissue graft rejection: current knowledge and future use. Exp. Biol. Med. 241, 955–961 (2016).

150. David, A. et al. Restoring ovarian endocrine function with encapsulated ovarian allograft in immune competent mice. Ann. Biomed. Eng. 45, 1685–1696 (2017).

151. Sittadjody, S. et al. In vivo transplantation of 3D encapsulated ovarian constructs in rats corrects abnormalities of ovarian failure. Nat. Commun. 8, 1858 (2017).

152. Yakhnenko, I., Wong, W. K., Katkov, I. I. & Itkin-Ansari, P. Cryopreservation of human insulin expressing cells macro-encapsulated in a durable therapeutic immunoisolating device theracyte. Cryo-Lett. 33, 518–531 (2012).

153. Veiseh, O. et al. Size- and shape-dependent foreign body immune response to materials implanted in rodents and non-human primates. Nat. Mater. 14, 643–651 (2015).

154. Calafiore, R. et al. Microencapsulated pancreatic islet allografts into nonimmunosuppressed patients with type 1 diabetes: first two cases. Diabetes Care 29, 137–138 (2006).

155. Edmonds, M. E., Orwig, K. E. & Brannigan, R. E. in Textbook of Oncofertility Research and Practice: A Multidisciplinary Approach (eds Woodruff, T. K. et al.) 385–394 (Springer, 2019).

156. Kaneko, H. et al. Generation of live piglets for the first time using sperm retrieved from immature testicular tissue cryopreserved and grafted into nude mice. PLoS ONE 8, e70989 (2013).

157. Hermann, B. P. et al. Spermatogonial stem cell transplantation into rhesus testes regenerates spermatogenesis producing functional sperm. Cell Stem Cell 11, 715–726 (2012).

158. Fayomi, A. P. et al. Autologous grafting of cryopreserved prepubertal rhesus testis produces sperm and offspring. Science 363, 1314–1319 (2019).

159. Liu, Z. et al. Generation of macaques with sperm derived from juvenile monkey testicular xenografts. Cell Res. 26, 139–142 (2016).

160. Ohta, H. & Wakayama, T. Generation of normal progeny by intracytoplasmic sperm injection following grafting of testicular tissue from cloned mice that died postnatally. Biol. Reprod. 73, 390–395 (2005).

161. Poels, J., Van Langendonckt, A., Many, M.-C., Wese, F.-X. & Wyns, C. Vitrification preserves proliferation capacity in human spermatogonia. Hum. Reprod. 28, 578–589 (2013).

162. Medrano, J. V. et al. Germ cell transplantation into mouse testes procedure. Fertil. Steril. 102, e11–e12 (2014).

163. Poels, J. et al. In search of better spermatogonial preservation by supplementation of cryopreserved human immature testicular tissue xenografts with N-acetylcysteine and testosterone. Front. Surg. 1, 47 (2014).

164. de Michele, F. et al. Haploid germ cells generated in organotypic culture of testicular tissue from prepubertal boys. Front. Physiol. 9, 1413 (2018).

165. Lee, K. H. et al. Vitrified canine testicular cells allow the formation of spermatogonial stem cells and seminiferous tubules following their xenotransplantation into nude mice. Sci. Rep. 6, 21919 (2016).

166. Honaramooz, A., Megee, S. O., Rathi, R. & Dobrinski, I. Building a testis: formation of functional testis tissue after transplantation of isolated porcine (Sus scrofa) Testis Cells. Biol. Reprod. 76, 43–47 (2007).

167. Brinster, R. L. Germline stem cell transplantation and transgenesis. Science 296, 2174–2176 (2002).

168. Xin, L. et al. A collagen scaffold loaded with human umbilical cord-derived mesenchymal stem cells facilitates endometrial regeneration and restores fertility. Acta Biomater. 92, 160–171 (2019).

169. Zhu, L., Zhou, H., Sun, Z., Lou, W. & Lang, J. Anatomic and sexual outcomes after vaginoplasty using tissue‐engineered biomaterial graft in patients with Mayer‐Rokitansky‐Küster‐Hauser syndrome: a new minimally invasive and effective surgery. J. Sex. Med. 10, 1652–1658 (2013).

170. Ding, J.-X., Chen, X.-J., Zhang, X.-y, Zhang, Y. & Hua, K.-Q. Acellular porcine small intestinal submucosa graft for cervicovaginal reconstruction in eight patients with malformation of the uterine cervix. Hum. Reprod. 29, 677–682 (2014).

171. Ding, J.-X., Zhang, X., Chen, L. & Hua, K.-Q. Vaginoplasty using acellular porcine small intestinal submucosa graft in two patients with Meyer-von-Rokitansky-Küster-Hauser syndrome: a prospective new technique for vaginal reconstruction. Gynecol. Obstet. Invest. 75, 93–96 (2013).

172. Li, Y. et al. Bone marrow mesenchymal stem cells could acquire the phenotypes of epithelial cells and accelerate vaginal reconstruction combined with small intestinal submucosa. Cell Biol. Int. 39, 1225–1233 (2015).

173. Pinto Medeiros Dias, M. T. et al. Tilapia fish skin as a new biologic graft for neovaginoplasty in Mayer-Rokitansky-Kuster-Hauser syndrome: a video case report. Fertil. Steril. 112, 174–176 (2019).

174. Dabaghi, M. et al. An artificial placenta type microfluidic blood oxygenator with double-sided gas transfer microchannels and its integration as a neonatal lung assist device. Biomicrofluidics 12, 044101 (2018).

175. Hunt, P. A. et al. Bisphenol a exposure causes meiotic aneuploidy in the female mouse. Curr. Biol. 13, 546–553 (2003).

176. ART Success Rates. Centers for Disease Control and Prevention https://www.cdc.gov/art/artdata/index.html (2019).

177. Campo-Engelstein, L., Chen, D., Baratz, A. B., Johnson, E. K. & Finlayson, C. The ethics of fertility preservation for pediatric patients with differences (disorders) of sex development. J. Endocr. Soc. 1, 638–645 (2017).

178. Woodruff, T. K., Zoloth, L., Campo-Engelstein, L. & Rodriguez, S. Oncofertility: ethical, legal, social, and medical perspectives. Preface. Cancer Treat. Res. 156, 5–7 (2010).

179. Segers, S., Mertes, H., de Wert, G., Dondorp, W. & Pennings, G. Balancing ethical pros and cons of stem cell derived gametes. Ann. Biomed. Eng. 45, 1620–1632 (2017).

180. Basco, D., Campo-Engelstein, L. & Rodriguez, S. Insuring against infertility: expanding state infertility mandates to include fertility preservation technology for cancer patients. J. Law Med. Ethics 38, 832–839 (2010).

181. Fleetwood, A. & Campo-Engelstein, L. The impact of infertility: why ART should be a higher priority for women in the global South. Canc. Treat. 156, 237–248 (2010).

182. Campo-Engelstein, L. Consistency in insurance coverage for iatrogenic conditions resulting from cancer treatment including fertility preservation. J. Clin. Oncol. 28, 1284–1286 (2010).

183. Chatzinikolaou, N. The ethics of assisted reproduction. J. Reprod. Immunol. 85, 3–8 (2010).

184. Brezina, P. R. & Zhao, Y. The ethical, legal, and social issues impacted by modern assisted reproductive technologies. Obstet. Gynecol. Int. 2012, 686253 (2012).

185. Campo-Engelstein, L. Offering testicular tissue cryopreservation to boys: the increasing importance of biological fatherhood. Am. J. Bioeth. 13, 39–40 (2013).